3 unknown, 2 completed. 5 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Unknown 3, Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow icotinib: new trials by email Literature Review of icotinib trials Research Report on icotinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer icotinib, Gemcitabine - Pancreatic Cancer | Phase 1 | Unknown | Betta Pharmaceuticals Co., Ltd. | 24 | 2014-10-01 | 2015-05-22 |
| Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI Icotinib, Arsenic trioxide - Non-small Cell Lung Cancer | Phase 1 | Unknown | Betta Pharmaceuticals Co., Ltd. | 9 | 2014-01-01 | 2015-03-13 |
| Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer icotinib, Gemcitabine - Pancreatic Cancer | Phase 1 | Unknown | Betta Pharmaceuticals Co., Ltd. | 24 | 2013-12-01 | 2015-07-15 |
| Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma Icotinib, intensity-modulated radiotherapy, Paclitaxel and Cisplatin - Nasopharyngeal Carcinoma | Phase 1 / Phase 2 | Completed | Taizhou Hospital | 48 | 2012-02-01 | 2018-04-17 |
| Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation icotinib, Whole brain radiotherapy - Non-small Cell Lung Cancer, Brain Metastases | Phase 1 / Phase 2 | Completed | Betta Pharmaceuticals Co., Ltd. | 15 | 2011-12-01 | 2014-02-17 |
Carcinoma, Non-Small-Cell Lung (2) · Pancreatic Neoplasms (2) · Brain Neoplasms (1) · Nasopharyngeal Carcinoma (1)
Betta Pharmaceuticals Co., Ltd. (4) · Taizhou Hospital (1)
China (5)
Chao Zhou, MD. (1) · Haihua Yang, MD. (1) · Saijuan Chen, MD (1) · Tingbo Liang, MD (1) · Wei Hu, MD. (1) · Wei Wang, BS (1) · Yanqiao Zhang, MD (1) · You Lu (1) · Yuankai Shi, MD (1)